ArticleCancer biology & therapy2015

Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies.

Thomas K Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.